340B drug discount program yields mixed evidence on how hospitals use funds

Healthcare DIVE November 27, 2023
Rebecca Pifer

Researchers reviewed almost 300 pieces of literature on 340B and found some studies suggested hospitals were using savings from the program for purposes “seemingly unrelated” to patient care.

Dive Brief:

• Amid ongoing controversy over 340B drug discounts, a sweeping review suggests the program is doing what it was intended to do: generate revenue for hospitals, clinics and pharmacies by requiring drugmakers to give them discounts on medications.
• Yet researchers — who reviewed almost 300 pieces of literature on 340B for the new analysis — found mixed evidence on whether hospitals and clinics are using 340B revenue as intended, to care for low-income patients.
• That’s been a major criticism of the drug discount program, as drugmakers and some legislators say...

Today's Sponsors

Today's Sponsor